Ann: Quarterly update and Appendix 4C, page-5

I think that is the question many GSS investors are asking, how long will PCR/RAT tests play a role with the pandemic and how long can GSS rely on this cash cow.

IMHO Covid is here to stay and whilst it will likely normalise in most people minds, with most governments now moving away from a Covid Zero / eradication policy they had previously adopted, testing will continue to play an important part for treatment and with many borders now opening up internationally I am sure we will continue to see new variants and epidemics in certain countries across the globe flair up.

Whilst sales of the SARS-CoV-2 will likely plateau, it will continue to play an important role in funding GSS R&D and launching other product lines without the need of a capital raise.